Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2026 06:31 ET | Source: Johnson & Johnson EMEA

Johnson & Johnson’s DARZALEX® (daratumumab) becomes the first oncology injectable approved for administration by patients or caregivers

Landmark decision by CHMP grants approval for self or caregiver administration for patients living with multiple myeloma1 Milestone is a testament to ten years of daratumumab experience and...
May 15, 2025 09:43 ET | Source: Research and Markets

Daratumumab or Darzalex Market Research Report 2025: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2019-2024, 2024-2029F, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Daratumumab or Darzalex Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
April 30, 2025 04:49 ET | Source: Research and Markets

Darzalex Faspro Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Darzalex Faspro Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...